$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 50/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 50/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 19 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 3,264 | 99,976 | 0 | |
Dec 19 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 3,264 | 99,976 | 18,705 | 15.4 K to 18.7 K (+21.14 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | A | 399.66 | 108,380 | 43,315,151 | 108,380 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 7,820 | 0 | 0 | 7.8 K to 0 (-100.00 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 591 | 0 | 155,777 | 156.4 K to 155.8 K (-0.38 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 24,900 | 0 | 369,093 | 394 K to 369.1 K (-6.32 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | A | 399.66 | 80,750 | 32,272,545 | 80,750 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | A | 52.03 | 75,000 | 3,902,250 | 123,079 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 30.63 | 3,264 | 99,976 | 0 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 30.63 | 3,264 | 99,976 | 6,541 | 3.3 K to 6.5 K (+99.60 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 399.66 | 203,204 | 81,212,511 | 203,204 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 52.03 | 240,000 | 12,487,200 | 400,000 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | A | 399.66 | 40,000 | 15,986,400 | 40,000 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | A | 52.03 | 52,500 | 2,731,575 | 85,579 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Option Exercise | A | 52.03 | 60,000 | 3,121,800 | 78,079 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Option Exercise | M | 30.63 | 3,264 | 99,976 | 0 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Buy | M | 30.63 | 3,264 | 99,976 | 64,436 | 61.2 K to 64.4 K (+5.34 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Gift | G | 0.00 | 1,930 | 0 | 61,172 | 63.1 K to 61.2 K (-3.06 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | A | 399.66 | 30,000 | 11,989,800 | 30,000 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | A | 399.66 | 34,000 | 13,588,440 | 34,000 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | A | 399.66 | 172,723 | 69,030,474 | 172,723 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | A | 52.03 | 240,000 | 12,487,200 | 398,079 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | M | 30.63 | 3,264 | 99,976 | 0 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 3,264 | 0 | 569,588 | 566.3 K to 569.6 K (+0.58 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 2,313 | 0 | 566,324 | 568.6 K to 566.3 K (-0.41 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 294 | 0 | 568,637 | 568.3 K to 568.6 K (+0.05 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 3,264 | 0 | 500,000 | 503.3 K to 500 K (-0.65 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Buy | M | 30.63 | 3,264 | 99,976 | 503,264 | 500 K to 503.3 K (+0.65 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 294 | 0 | 500,000 | 500.3 K to 500 K (-0.06 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Option Exercise | A | 399.66 | 34,000 | 13,588,440 | 34,000 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Option Exercise | A | 52.03 | 48,000 | 2,497,440 | 62,079 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Option Exercise | A | 399.66 | 34,000 | 13,588,440 | 34,000 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Option Exercise | A | 52.03 | 6,000 | 312,180 | 10,000 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 399.66 | 40,000 | 15,986,400 | 40,000 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 52.03 | 48,750 | 2,536,463 | 79,329 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 2,800 | 85,764 | 464 | |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 2,800 | 85,764 | 7,481 | 4.7 K to 7.5 K (+59.82 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | A | 399.66 | 17,000 | 6,794,220 | 17,000 | |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 52.03 | 5,875 | 305,676 | 3,954 | |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 943 | 28,884 | 0 | |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 1,368 | 41,902 | 943 | |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 100 | 3,063 | 2,311 | |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 100 | 3,063 | 2,411 | |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 100 | 3,063 | 2,511 | |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 410.00 | 5,875 | 2,408,750 | 4,681 | 10.6 K to 4.7 K (-55.66 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 52.03 | 5,875 | 305,676 | 10,556 | 4.7 K to 10.6 K (+125.51 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 410.00 | 943 | 386,630 | 4,681 | 5.6 K to 4.7 K (-16.77 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 943 | 28,884 | 5,624 | 4.7 K to 5.6 K (+20.15 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 410.16 | 1,368 | 561,099 | 4,681 | 6 K to 4.7 K (-22.62 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 1,368 | 41,902 | 6,049 | 4.7 K to 6 K (+29.22 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 411.06 | 100 | 41,106 | 4,681 | 4.8 K to 4.7 K (-2.09 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 100 | 3,063 | 4,781 | 4.7 K to 4.8 K (+2.14 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 412.05 | 100 | 41,205 | 4,681 | 4.8 K to 4.7 K (-2.09 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 100 | 3,063 | 4,781 | 4.7 K to 4.8 K (+2.14 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 417.34 | 100 | 41,734 | 4,681 | 4.8 K to 4.7 K (-2.09 %) |
Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 100 | 3,063 | 4,781 | 4.7 K to 4.8 K (+2.14 %) |